IL164391A0 - Medicaments containing steroids and a novel anticholinesterase drug - Google Patents

Medicaments containing steroids and a novel anticholinesterase drug

Info

Publication number: IL164391A0
Authority: IL; Israel
Prior art keywords: medicaments containing; containing steroids; anticholinesterase drug; novel; novel anticholinesterase
Prior art date: 2002-04-12

Application number

IL16439103A

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-12

Filing date

2003-04-09

Publication date

2005-12-18

2003-04-09 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2005-12-18 Publication of IL164391A0 publication Critical patent/IL164391A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Dispersion Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL16439103A 2002-04-12 2003-04-09 Medicaments containing steroids and a novel anticholinesterase drug IL164391A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10216429A DE10216429A1 (en)	2002-04-12	2002-04-12	Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide
PCT/EP2003/003668 WO2003086399A1 (en)	2002-04-12	2003-04-09	Medicaments containing steroids and a novel anticholinesterase drug

Publications (1)

Publication Number	Publication Date
IL164391A0 true IL164391A0 (en)	2005-12-18

Family

ID=28458802

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16439103A IL164391A0 (en)	2002-04-12	2003-04-09	Medicaments containing steroids and a novel anticholinesterase drug
IL164391A IL164391A (en)	2002-04-12	2004-10-04	Medicaments containing steroids and a novel anticholinesterase drug optionally as propellant-containing inhalable aerosol

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL164391A IL164391A (en)	2002-04-12	2004-10-04	Medicaments containing steroids and a novel anticholinesterase drug optionally as propellant-containing inhalable aerosol

Country Status (29)

Country	Link
EP (2)	EP1496902B1 (en)
JP (1)	JP4559086B2 (en)
KR (1)	KR101010869B1 (en)
CN (1)	CN1646126A (en)
AR (1)	AR039275A1 (en)
AT (1)	ATE312607T1 (en)
AU (1)	AU2003216921B2 (en)
BR (1)	BR0309085A (en)
CA (1)	CA2481268C (en)
DE (2)	DE10216429A1 (en)
DK (1)	DK1496902T3 (en)
EA (1)	EA008386B1 (en)
EC (1)	ECSP045355A (en)
ES (1)	ES2254917T3 (en)
HR (1)	HRP20040943B1 (en)
IL (2)	IL164391A0 (en)
ME (1)	MEP54208A (en)
MX (1)	MXPA04009917A (en)
MY (1)	MY137045A (en)
NO (1)	NO20044097L (en)
NZ (1)	NZ536284A (en)
PE (1)	PE20040326A1 (en)
PL (1)	PL211227B1 (en)
RS (1)	RS50776B (en)
TW (1)	TWI311055B (en)
UA (1)	UA80125C2 (en)
UY (1)	UY27758A1 (en)
WO (1)	WO2003086399A1 (en)
ZA (1)	ZA200406751B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (en)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GB0019172D0 (en)	2000-08-05	2000-09-27	Glaxo Group Ltd	Novel compounds
US6777399B2 (en)	2000-08-05	2004-08-17	Smithkline Beecham Corporation	Anti-inflammatory androstane derivative compositions
US6858596B2 (en)	2000-08-05	2005-02-22	Smithkline Beecham Corporation	Formulation containing anti-inflammatory androstane derivative
CA2445839A1 (en)	2001-04-30	2002-11-07	Glaxo Group Limited	Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
ES2413011T3 (en) *	2004-02-06	2013-07-15	Meda Pharma Gmbh & Co. Kg	Combination of anticholinergics and glucocorticoids for long-term treatment of asthma and COPD
EP2100598A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
PL3111926T3 (en)	2009-05-29	2020-06-29	Pearl Therapeutics, Inc.	Compositions, methods, and systems for delivering two or more active agents to the respiratory system
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
CA2905542C (en)	2013-03-15	2022-05-03	Pearl Therapeutics, Inc.	Methods and systems for conditioning of particulate crystalline materials
CN115282411A (en) *	2022-01-14	2022-11-04	温州医科大学	A delivery system for delivering drugs into the brain using the nose and olfactory region and its application method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
CA1272917A (en)	1985-07-30	1990-08-21	Paul Kenneth Rand	Devices for administering medicaments to patients
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
DE4108393A1 (en) *	1991-03-15	1992-09-17	Boehringer Ingelheim Kg	NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
IL107120A (en)	1992-09-29	1997-09-30	Boehringer Ingelheim Int	Atomising nozzle and filter and spray generating device
DE4318455A1 (en)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Capsule holder
DE69632728T2 (en) *	1995-04-28	2004-10-14	Banyu Pharmaceutical Co., Ltd.	1,4-DISUBSTITUTED PIPERID DERIVATIVES
DE19536902A1 (en)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Miniature fluid pressure generating device
DE19536903C2 (en)	1995-10-04	1998-09-10	Boehringer Ingelheim Int	Device for holding a fluidic component
DE19545226C1 (en)	1995-12-05	1997-06-19	Boehringer Ingelheim Int	Locking mechanism for a spring-operated output
GB0009591D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Medical combinations
DE10050994A1 (en) *	2000-10-14	2002-04-18	Boehringer Ingelheim Pharma	New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
JP2004512359A (en) *	2000-10-31	2004-04-22	ベーリンガー　インゲルハイム　ファルマ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング　ウント　コンパニー　コマンディトゲゼルシャフト	Novel pharmaceutical compositions based on anticholinergics and corticosteroids

2002
- 2002-04-12 DE DE10216429A patent/DE10216429A1/en not_active Withdrawn
2003
- 2003-04-09 ES ES03712137T patent/ES2254917T3/en not_active Expired - Lifetime
- 2003-04-09 DK DK03712137T patent/DK1496902T3/en active
- 2003-04-09 MX MXPA04009917A patent/MXPA04009917A/en active IP Right Grant
- 2003-04-09 CN CNA038083299A patent/CN1646126A/en active Pending
- 2003-04-09 EA EA200401303A patent/EA008386B1/en not_active IP Right Cessation
- 2003-04-09 JP JP2003583418A patent/JP4559086B2/en not_active Expired - Lifetime
- 2003-04-09 CA CA2481268A patent/CA2481268C/en not_active Expired - Lifetime
- 2003-04-09 ME MEP-542/08A patent/MEP54208A/en unknown
- 2003-04-09 EP EP03712137A patent/EP1496902B1/en not_active Expired - Lifetime
- 2003-04-09 AU AU2003216921A patent/AU2003216921B2/en not_active Expired
- 2003-04-09 PL PL371561A patent/PL211227B1/en not_active IP Right Cessation
- 2003-04-09 KR KR1020047016335A patent/KR101010869B1/en not_active Expired - Fee Related
- 2003-04-09 RS YUP-899/04A patent/RS50776B/en unknown
- 2003-04-09 HR HRP20040943AA patent/HRP20040943B1/en not_active IP Right Cessation
- 2003-04-09 WO PCT/EP2003/003668 patent/WO2003086399A1/en not_active Ceased
- 2003-04-09 AT AT03712137T patent/ATE312607T1/en active
- 2003-04-09 DE DE50301934T patent/DE50301934D1/en not_active Expired - Lifetime
- 2003-04-09 NZ NZ536284A patent/NZ536284A/en not_active IP Right Cessation
- 2003-04-09 IL IL16439103A patent/IL164391A0/en unknown
- 2003-04-09 EP EP05109887A patent/EP1621197A3/en not_active Withdrawn
- 2003-04-09 BR BR0309085-0A patent/BR0309085A/en not_active IP Right Cessation
- 2003-04-09 AR ARP030101241A patent/AR039275A1/en unknown
- 2003-04-10 TW TW092108227A patent/TWI311055B/en not_active IP Right Cessation
- 2003-04-10 MY MYPI20031320A patent/MY137045A/en unknown
- 2003-04-10 PE PE2003000365A patent/PE20040326A1/en not_active Application Discontinuation
- 2003-04-10 UY UY27758A patent/UY27758A1/en not_active Application Discontinuation
- 2003-09-04 UA UA20041109192A patent/UA80125C2/en unknown
2004
- 2004-08-25 ZA ZA200406751A patent/ZA200406751B/en unknown
- 2004-09-27 NO NO20044097A patent/NO20044097L/en not_active Application Discontinuation
- 2004-10-04 IL IL164391A patent/IL164391A/en not_active IP Right Cessation
- 2004-10-11 EC EC2004005355A patent/ECSP045355A/en unknown

Also Published As

Publication number	Publication date
DK1496902T3 (en)	2006-05-08
RS50776B (en)	2010-08-31
RS89904A (en)	2006-10-27
KR20050000391A (en)	2005-01-03
PE20040326A1 (en)	2004-07-13
UY27758A1 (en)	2003-11-28
IL164391A (en)	2010-11-30
PL371561A1 (en)	2005-06-27
EP1621197A2 (en)	2006-02-01
ZA200406751B (en)	2006-12-27
MXPA04009917A (en)	2004-12-07
ATE312607T1 (en)	2005-12-15
BR0309085A (en)	2005-02-09
TW200403062A (en)	2004-03-01
UA80125C2 (en)	2007-08-27
CA2481268C (en)	2011-07-12
ES2254917T3 (en)	2006-06-16
AU2003216921B2 (en)	2008-03-13
HRP20040943A2 (en)	2005-04-30
AR039275A1 (en)	2005-02-16
MY137045A (en)	2008-12-31
NZ536284A (en)	2006-11-30
NO20044097L (en)	2004-11-04
JP2005529105A (en)	2005-09-29
JP4559086B2 (en)	2010-10-06
CN1646126A (en)	2005-07-27
EA008386B1 (en)	2007-04-27
TWI311055B (en)	2009-06-21
EP1621197A3 (en)	2010-01-06
EP1496902B1 (en)	2005-12-14
AU2003216921A1 (en)	2003-10-27
WO2003086399A1 (en)	2003-10-23
MEP54208A (en)	2011-05-10
CA2481268A1 (en)	2003-10-23
KR101010869B1 (en)	2011-01-26
EP1496902A1 (en)	2005-01-19
ECSP045355A (en)	2005-01-28
HRP20040943B1 (en)	2013-05-31
DE50301934D1 (en)	2006-01-19
PL211227B1 (en)	2012-04-30
DE10216429A1 (en)	2003-10-23
EA200401303A1 (en)	2005-04-28

Publication	Publication Date	Title
EP1581281A4 (en)	2007-06-27	Inhalation device for producing a drug aerosol
IL166747A0 (en)	2006-01-15	Water-soluble iron-carbohydrate complexes production thereof and medicaments containing said complexes
EP1581281A3 (en)	2005-09-15	Inhalation device for producing a drug aerosol
GB0201677D0 (en)	2002-03-13	Medicament dispenser
GB0217198D0 (en)	2002-09-04	Medicament dispenser
GB0217196D0 (en)	2002-09-04	Medicament dispenser
GB0217199D0 (en)	2002-09-04	Medicament dispenser
GB0216831D0 (en)	2002-08-28	Medicament dispenser
GB0209526D0 (en)	2002-06-05	Medicament dispenser
IL164391A0 (en)	2005-12-18	Medicaments containing steroids and a novel anticholinesterase drug
AU2002257562A1 (en)	2003-04-17	Deuterated 3-Piperidinopropiophenone and medicaments containing said compounds
GB0206861D0 (en)	2002-05-01	Medicaments
HRP20041193A2 (en)	2005-06-30	Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
GB2409645B (en)	2006-03-01	Flower essence-containing medicaments
AU2003233083A8 (en)	2003-11-10	Medicament dispenser
AUPS286302A0 (en)	2002-06-27	Medication inhaler
AU2002367117A1 (en)	2003-07-15	A medicine dispensing system and components thereof
ZA200406881B (en)	2006-06-28	Medicaments containing betamimetic drugs and a novel anticholineterase drug
AU2003246489A8 (en)	2004-02-09	Oral delivery system containing a gel matrix and liposomes
PL376744A1 (en)	2006-01-09	Pharmaceutical tablets containing tibolone and a coating
GB0215593D0 (en)	2002-08-14	New anticancer drugs
GB2383988B (en)	2005-08-10	Pill dispenser
HRP20050430A2 (en)	2005-06-30	Pharmaceutical tablets containing tibolone and a coating
AU2003229137A8 (en)	2003-12-22	Medication inhaler
AU2003217453A1 (en)	2003-09-09	Pre-dosed container for a medicinal product and method for its construction